Roivant Sciences (ROIV) Accounts Payables (2021 - 2026)

Roivant Sciences (ROIV) has reported Accounts Payables for 6 consecutive years, with $25.1 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Accounts Payables rose 117.18% year-over-year to $25.1 million; the trailing twelve-month figure through Jun 2026 stood at $25.1 million (up 117.18% YoY), and the FY2026 full-year result was $18.0 million, down 24.01% from the prior year.
• Accounts Payables rose to $25.1 million in Q2 2026 per ROIV's latest filing, from $18.0 million in the prior quarter.
• Across five years, Accounts Payables topped out at $161.3 million in Q2 2022 and bottomed at $11.5 million in Q2 2025.
• Historically, Accounts Payables has averaged $36.1 million across 5 years, with a median of $26.4 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Accounts Payables jumped 974.36% in 2022, then sank 68.98% in 2023.
• Over 5 years, Accounts Payables stood at $48.0 million in 2022, then decreased by 26.61% to $35.2 million in 2023, then sank by 32.69% to $23.7 million in 2024, then tumbled by 43.94% to $13.3 million in 2025, then jumped by 88.69% to $25.1 million in 2026.
• According to Business Quant data, Accounts Payables over the past three periods registered $25.1 million, $18.0 million, and $13.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.